Results 181 to 190 of about 209,693 (354)

Circulating T-lymphocyte subsets as biomarkers for immune checkpoint inhibitors in solid tumors. [PDF]

Clin Exp Immunol
Kong Y, Chen R, Zhang J, Zhang L.
europepmc   +1 more source

Frequent somatic mosaicism in T lymphocyte subsets in individuals with and without multiple sclerosis. [PDF]

Front Immunol, 2022
Van Horebeek L, Dedoncker N, Dubois B, Goris A.   +3 more
europepmc   +1 more source

Lymphocyte Subsets and Mitogen Induced Proliferation in Adjuvant Arthritis. Part II. Changes in Function and Numbers of Lymph Nodes T Lymphocytes.

, 1992
Ching‐Lin Tsai, Tang‐Kue Liu
openalex   +2 more sources

Profiling Localized Immunomodulation and Drug Biodistribution within a Subcutaneous Vascularized Niche for Cell Transplantation

Advanced Science, EarlyView.
We studied how five common immunosuppressants behave when delivered directly to a transplant site instead of systemically. Using a vascularized implant for islet transplantation, we show that local delivery protects grafts, limits drug spread to the rest of the body, and produces distinct immune signatures.
Jocelyn Nikita Campa‐Carranza, Simone Capuani, Melissa A. Willman, Alexander Rabassa, Ashley L. Joubert, Tommaso Bo, Letizia Franco, Marzia Conte, Ana L. Anaya‐García, Gabrielle E. Rome, Rim Ouni, Henry J. Seaborne, Camden A. Caffey, Dora M. Berman, Junjun Zheng, Jesus Paez‐Mayorga, Corrine Ying Xuan Chua, Shu Hsia Chen, Norma S. Kenyon, Alessandro Grattoni   +19 more
wiley   +1 more source

A therapy that modulates T lymphocyte subsets in patients infected with Epstein-Barr virus: Ganciclovir combined with interferon atomization inhalation. [PDF]

Medicine (Baltimore), 2023
Ren Q, Feng Y.
europepmc   +1 more source

Immune Checkpoint Inhibitors and Immunomodulators for Cancer Immunotherapy: Insights Into Resistance and Therapeutic Strategies

Advanced Science, EarlyView.
The schematic diagram illustrates the roles of novel immune checkpoints, immunomodulatory factors, cell death and multimodal technologies in cancer immunotherapy. Abstract Cancer immunotherapy has redefined cancer treatment. However, the molecular and cellular basis of immune evasion and therapeutic resistance remains incompletely understood.
Fangquan Chen, Yang Yu, Xiutao Cai, Junhao Lin, Ruirui Liang, Rui Kang, Daolin Tang, Jiao Liu   +7 more
wiley   +1 more source

Changes in T lymphocyte subsets in patients with acute neuromyelitis optica spectrum disorder. [PDF]

Front Immunol
Shao YZ, Tan TF, Zhang LJ, Zhao N, Yang L, Zhang QX.   +5 more
europepmc   +1 more source

Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis. [PDF]

Front Pharmacol, 2022
Guo RH, Cheng H, Zhang XY, Yu Z, Wang GH, Hao SY, Gao XP, Wen HY.   +7 more
europepmc   +1 more source

Generation of CCR4/CD7 Bispecific CAR‐T Cells Resistant to Fratricide and Exhaustion

Advanced Science, EarlyView.
The applications of CAR T‐cell therapy in T‐cell malignancies face limitations such as fratricide, effector‐cell exhaustion, and antigen‐escape. Herein, we developed fratricide‐ and exhaustion‐resistant CAR‐T cells that targeted CCR4 and CD7 simultaneously, with optional EGFRt safety switch. Additionally, scRNA‐seq unveiled new molecular targets, which
Sile Li, Yuanxin Li, Asif Rashid, Hong Kee Tan, Shing Chan, Man Yan Hui, Wilson Yau Ki Chan, Kee See Lam, Yinping Liu, Wenwei Tu, Wing Leung   +10 more
wiley   +1 more source

Characteristics of T-lymphocyte subsets in patients with severe fever with thrombocytopenia syndrome complicated with invasive pulmonary aspergillosis: a retrospective study. [PDF]

Front Immunol
Xu Y, Liu Y, Qian Y, Liu N, Tang J, Dong D, Xia M, Wu W, Gu Q.   +8 more
europepmc   +1 more source